The SUMO Pathway in Hematomalignancies and Their Response to Therapies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The SUMO Pathway in Hematomalignancies and Their Response to Therapies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 16, Pages 3895
Publisher
MDPI AG
Online
2019-08-09
DOI
10.3390/ijms20163895
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic therapy in hematological cancers
- (2019) Konstantinos Dimopoulos et al. APMIS
- 2-D08 as a SUMOylation inhibitor induced ROS accumulation mediates apoptosis of acute myeloid leukemia cells possibly through the deSUMOylation of NOX2
- (2019) Pan Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Multiple myeloma: Every year a new standard?
- (2019) S. Vincent Rajkumar HEMATOLOGICAL ONCOLOGY
- Targeting the SUMO Pathway Primes All-transRetinoic Acid–Induced Differentiation of Nonpromyelocytic Acute Myeloid Leukemias
- (2018) Hayeon Baik et al. CANCER RESEARCH
- The post-translational modification, SUMOylation, and cancer (Review)
- (2018) Zhi-Jian Han et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- SUMO-specific proteases and isopeptidases of the SENP family at a glance
- (2018) Kathrin Kunz et al. JOURNAL OF CELL SCIENCE
- Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds
- (2018) Yanfang Yang et al. MOLECULAR PHARMACOLOGY
- The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
- (2018) Antonella Di Costanzo et al. ONCOGENE
- Control of SUMO and Ubiquitin by ROS: Signaling and disease implications
- (2018) Nicolas Stankovic-Valentin et al. MOLECULAR ASPECTS OF MEDICINE
- SUMO-Mediated Regulation of Nuclear Functions and Signaling Processes
- (2018) Xiaolan Zhao MOLECULAR CELL
- SUMO Safeguards Somatic and Pluripotent Cell Identities by Enforcing Distinct Chromatin States
- (2018) Jack-Christophe Cossec et al. Cell Stem Cell
- Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme
- (2018) Zongyang Lv et al. Nature Communications
- Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression
- (2017) Caroline Bonet et al. JNCI-Journal of the National Cancer Institute
- HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression
- (2017) M Terol et al. LEUKEMIA
- Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
- (2017) Xingyue He et al. Nature Chemical Biology
- Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation
- (2017) Ivo A Hendriks et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SUMO, a small, but powerful, regulator of double-strand break repair
- (2017) Alexander J. Garvin et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation
- (2017) Ivo A Hendriks et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression
- (2017) Caroline Bonet et al. JNCI-Journal of the National Cancer Institute
- Small Ubiquitin-Like Modifier 4 (SUMO4) Gene M55V Polymorphism and Type 2 Diabetes Mellitus: A Meta-analysis Including 6,823 Subjects
- (2017) Yan-yan Li et al. Frontiers in Endocrinology
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Redox regulation of SUMO enzymes is required for ATM activity and survival in oxidative stress
- (2016) Nicolas Stankovic‐Valentin et al. EMBO JOURNAL
- A comprehensive compilation of SUMO proteomics
- (2016) Ivo A. Hendriks et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PIAS1 Promotes Lymphomagenesis through MYC Upregulation
- (2016) Andrea Rabellino et al. Cell Reports
- SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies
- (2016) Ya-Chen Liang et al. Scientific Reports
- SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling
- (2015) Jun Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SUMO-regulated transcription: Challenging the dogma
- (2015) Pierre Chymkowitch et al. BIOESSAYS
- An update of current treatments for adult acute myeloid leukemia
- (2015) H. Dombret et al. BLOOD
- An ATRActive future for differentiation therapy in AML
- (2015) Daniel E. Johnson et al. BLOOD REVIEWS
- SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia
- (2015) Song Dong et al. BMC CANCER
- SUMOylation of insulin-like growth factor 1 receptor, promotes proliferation in acute myeloid leukemia
- (2015) Jian Zhang et al. CANCER LETTERS
- c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4
- (2015) Román González-Prieto et al. CELL CYCLE
- Novel therapeutic strategies for multiple myeloma
- (2015) Naoya Mimura et al. EXPERIMENTAL HEMATOLOGY
- SUMO pathway components as possible cancer biomarkers
- (2015) Domenico Mattoscio et al. Future Oncology
- RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway
- (2015) Jenny Xie et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple myeloma
- (2015) Christoph Röllig et al. LANCET
- The multifaceted functions of C/EBPα in normal and malignant haematopoiesis
- (2015) E Ohlsson et al. LEUKEMIA
- Defining and treating high-risk multiple myeloma
- (2015) S Z Usmani et al. LEUKEMIA
- Dynamics of ceramide generation and metabolism in response to fenretinide – Diversity within and among leukemia
- (2015) Samy A.F. Morad et al. LEUKEMIA RESEARCH
- A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assembly
- (2015) Nathalie Eisenhardt et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis for catalytic activation by the human ZNF451 SUMO E3 ligase
- (2015) Laurent Cappadocia et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9
- (2015) Bing Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteotoxic stress reprograms the chromatin landscape of SUMO modification
- (2015) Anne Seifert et al. Science Signaling
- Sumo and the cellular stress response
- (2015) Jorrit M. Enserink Cell Division
- Crizotinib resistance in acute myeloid leukemia with inv(2)(p23q13)/RAN binding protein 2 (RANBP2) anaplastic lymphoma kinase (ALK) fusion and monosomy 7
- (2015) Kayo Takeoka et al. Cancer Genetics
- A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assembly
- (2015) Nathalie Eisenhardt et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis for catalytic activation by the human ZNF451 SUMO E3 ligase
- (2015) Laurent Cappadocia et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver
- (2015) Miyuki Suzawa et al. eLife
- Proteotoxic stress reprograms the chromatin landscape of SUMO modification
- (2015) Anne Seifert et al. Science Signaling
- Synthesis of 2′,3′,4′-trihydroxyflavone (2-D08), an inhibitor of protein sumoylation
- (2014) Yeong Sang Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation
- (2014) Z. Dassouki et al. BLOOD
- Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma
- (2014) A. Hoellein et al. BLOOD
- Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α
- (2014) Qian Zhou et al. FEBS Journal
- Identification ofRANBP2-ALKfusion inALKpositive diffuse large B-cell lymphoma
- (2014) Seung Eun Lee et al. HEMATOLOGICAL ONCOLOGY
- Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata
- (2014) Misao Takemoto et al. JOURNAL OF ANTIBIOTICS
- Oxidative stress–induced assembly of PML nuclear bodies controls sumoylation of partner proteins
- (2014) Umut Sahin et al. JOURNAL OF CELL BIOLOGY
- Reduction of leukemia cell burden and restoration of normal hematopoiesis at 3 months of crizotinib treatment in RAN-binding protein 2 (RANBP2)–anaplastic lymphoma kinase (ALK) acute myeloid leukemia
- (2014) Y Maesako et al. LEUKEMIA
- Identification of Regulators of the Three-Dimensional Polycomb Organization by a Microscopy-Based Genome-wide RNAi Screen
- (2014) Inma Gonzalez et al. MOLECULAR CELL
- Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
- (2014) Julien Ablain et al. NATURE MEDICINE
- NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation
- (2014) M P Licciardello et al. ONCOGENE
- SUMOylation of Myc-Family Proteins
- (2014) Arianna Sabò et al. PLoS One
- RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia
- (2014) Ji-Hun Lim et al. Cancer Genetics
- The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs
- (2014) Guillaume Bossis et al. Cell Reports
- Spectomycin B1 as a Novel SUMOylation Inhibitor That Directly Binds to SUMO E2
- (2013) Mikako Hirohama et al. ACS Chemical Biology
- An Electrophoretic Mobility Shift Assay Identifies a Mechanistically Unique Inhibitor of Protein Sumoylation
- (2013) Yeong Sang Kim et al. CHEMISTRY & BIOLOGY
- The SUMO system: a master organizer of nuclear protein assemblies
- (2013) Nithya Raman et al. CHROMOSOMA
- Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation
- (2013) H. Neyret-Kahn et al. GENOME RESEARCH
- Protein Group Modification and Synergy in the SUMO Pathway as Exemplified in DNA Repair
- (2012) Ivan Psakhye et al. CELL
- Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions
- (2012) Sarah Schulz et al. EMBO REPORTS
- SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage
- (2012) Y. Yin et al. GENES & DEVELOPMENT
- A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm
- (2012) C Gervais et al. LEUKEMIA
- Role and potential for therapeutic targeting of MYB in leukemia
- (2012) D R Pattabiraman et al. LEUKEMIA
- The RanBP2/RanGAP1∗SUMO1/Ubc9 Complex Is a Multisubunit SUMO E3 Ligase
- (2012) Andreas Werner et al. MOLECULAR CELL
- Crystal structure of DeSI-1, a novel deSUMOylase belonging to a putative isopeptidase superfamily
- (2012) Hye-Young Suh et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- HTLV Tax: A Fascinating Multifunctional Co-Regulator of Viral and Cellular Pathways
- (2012) Robert Currer et al. Frontiers in Microbiology
- Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
- (2011) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax
- (2011) K. A. Fryrear et al. BLOOD
- A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
- (2011) Corine Bertolotto et al. NATURE
- Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation
- (2011) I Nishikata et al. ONCOGENE
- A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
- (2011) J. D. Kessler et al. SCIENCE
- PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
- (2010) Marion Jeanne et al. CANCER CELL
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
- (2010) Hiba El Hajj et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability
- (2010) T Sæther et al. ONCOGENE
- The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
- (2009) J. J. Driscoll et al. BLOOD
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- (2009) G. Kchour et al. BLOOD
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
- (2009) Ji Luo et al. CELL
- Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
- (2009) Isao Fukuda et al. CHEMISTRY & BIOLOGY
- Kerriamycin B inhibits protein SUMOylation
- (2009) Isao Fukuda et al. JOURNAL OF ANTIBIOTICS
- Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks
- (2009) Yaron Galanty et al. NATURE
- SUMO under stress: Figure 1
- (2008) Denis Tempé et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Sumo-1 Function Is Dispensable in Normal Mouse Development
- (2008) F.-P. Zhang et al. MOLECULAR AND CELLULAR BIOLOGY
- RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
- (2008) Michael H. Tatham et al. NATURE CELL BIOLOGY
- Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
- (2008) Valérie Lallemand-Breitenbach et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation